When was Huameihaolian founded?

Huameihaolian was founded in 2021.

Where is Huameihaolian located?

Huameihaolian is located in China .

Is Huameihaolian a funded company?

Huameihaolian is a funded company, its first funding round was on Jun 23, 2022.

When was the latest funding round of Huameihaolian?

Huameihaolian's latest funding round was on May 30, 2023.

Where does Huameihaolian rank among its competitors?

Huameihaolian ranks 10 amongst 331 active competitors.

Who are the top competitors of Huameihaolian?

Huameihaolian's top competitors are OPEN Health, Target RWE and Secura Bio.

Huameihaolian - 2025 Company Profile, Funding & Competitors

Huameihaolian is a series B company based in China, founded in 2021. It operates as a Provider of commercial services for biopharma sector. Huameihaolian has raised an undisclosed amount in funding from Borchid Capital and GSR Ventures. The company has 331 active competitors, including 9 funded and 42 that have exited. Its top competitors include companies like OPEN Health, Target RWE and Secura Bio.

Key Metrics

Founded Year

2021

Location

China

Stage

Series B

Latest Funding Round

Investors

Borchid Capital & 4 more

Ranked

10^th among

Similar Companies

OPEN Health &

Get your free copy of Huameihaolian's company profile

Huameihaolian has raised funding over 3 rounds. Its first funding round was on Jun 23, 2022. Its latest funding round was a Series B round on May 30, 2023 for an undisclosed amount. 2 investors participated in its latest round, which includes Ventech China, GSR Ventures, Borchid Capital and Langrun Financial Group.

Huameihaolian has 5 institutional investors including Borchid Capital, GSR Ventures and Ventech China.

Here is the list of recent funding rounds of Huameihaolian:

Date of funding	Funding Amount	Round Name	Post money valuation	Revenue multiple	Investors
May 30, 2023	Undisclosed	Series B	8861952	6968147	Ventech China, GSR Ventures
Aug 15, 2022	Undisclosed	Series A	4383686	4377796	Borchid Capital, Tongji University Alumni Association
Jun 23, 2022	Undisclosed	Series A	2605988	1696102	GSR Ventures, Ventech China, and

Access funding benchmarks and valuations. Sign up today!

View details of Huameihaolian's funding rounds and investors

Top competitors of Huameihaolian include OPEN Health, Target RWE and Secura Bio. Here is the list of Top 10 competitors of Huameihaolian, ranked by 秘密研究所 score :

Overall Rank	Company Details	Short Description	Total Funding	Investors	秘密研究所 Score
1st	OPEN Health 2016, Marlow (United Kingdom), Acquired	Provider of healthcare marketing services	$5.28M	LBO France, Amulet Capital Partners	65/100
2nd	Target RWE 2017, Durham (United States), Acquired	Provider of marketing services to the pharmaceutical industry	-	Norwest Venture Partners, VentureSouth	50/100
3rd	Secura Bio 2018, Henderson (United States), Series A	Provider of consulting services for market access and health outcomes	$55M	Athyrium Capital Management	50/100
4th	STATinMED Research 2007, Ann Arbor (United States), Acquired	Healthcare data analytics services provider	-	Harbert Management, Capital Southwest听&补尘辫;听	49/100
5th	PBR 2015, London (United Kingdom), Seed	Provider of market research consulting services for life science sector	$1.12M	Techstars, Launch Africa听&补尘辫;听	48/100
6th	Abacus Medicine 2004, Copenhagen (Denmark), Series B	Consulting services for market access, health economics and outcomes research	$57.6M	Chr. Augustinus Fabrikker	47/100
7th	Hylant 1935, Toledo (United States), Unfunded	Insurance broker	-	-	45/100
8th	GBA Group 1975, Hamburg (Germany), Acquired	Provider of drinking water testing, environmental analysis, and marketing services to the pharmaceutical industry	-	Adiuva Capital	44/100
9th	bpcruk 2017, Public	Provider of marketing services to biopharma sector	-	Scientia Ventures	43/100
10th	Huameihaolian 2021, China, Series B	Provider of commercial services for biopharma sector	-	Ventech China, GSR Ventures听&补尘辫;听	23/100